Lastly, these studies demonstrated that CD38 activity increases pAMPK with subsequent inhibition of fatty acid and lipid synthesis [82], so loss of CD38 with tumor progression correlates with decreased pAMPK and increased fatty acid/lipid synthesis. Here, CD38 is linked to neoplasm.